Turning Point Therapeutics Reports Second-Quarter Financial Results, Provides Operational Updates

NEXT STORY
Tonix Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights
PREV STORY
SCYNEXIS Reports Second Quarter 2020 Financial Results and Provides Company Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cue Biopharma Presents Foundational Data on Immuno-STAT Platform and CUE-101 at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

CUE-101 Demonstrates Selective Binding and Preferential Activation/Expansion of Antigen-specific T Cells, Inhibition of Tumor ...

author_avatar
NASDAQ Market News

ABLYNX ANNOUNCES WARRANT EXERCISE

REGULATED INFORMATION GHENT, Belgium, 21 April 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] ...

author_avatar
NASDAQ Market News

Cesca Therapeutics Sponsors First Symposium on Haploidentical Stem Cell Transplantation in India

RANCHO CORDOVA, Calif., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an ...

author_avatar
NASDAQ Market News